Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ettinger, S. L.
Right arrow Articles by Duronio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ettinger, S. L.
Right arrow Articles by Duronio, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 24, Issue of June 14, 1996 pp. 14514-14518
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Protein Kinase C delta  Specifically Associates with Phosphatidylinositol 3-Kinase Following Cytokine Stimulation*

(Received for publication, March 14, 1996, and in revised form, April 22, 1996)

Susan L. Ettinger , Ron W. Lauener Dagger and Vincent Duronio §

From the Department of Medicine, Jack Bell Research Centre, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Phosphatidylinositol (PI) 3-kinase is activated as a result of cytokine-induced association of the enzyme with specific tyrosine-phosphorylated proteins. PI 3-kinase lipid products, PI 3,4-P2 and PI 3,4,5-P3, have been shown, in vitro, to directly activate novel and atypical protein kinase C (PKC) isozymes. However, the mechanism by which PI 3-kinase may be involved in regulation of PKC isoforms in vivo is presently unknown. We investigated a possible relationship by looking for associations between these enzymes. We found that in a human erythroleukemia cell line, as well as in rabbit platelets, PI 3-kinase and PKCdelta associate in a specific manner that is modulated by cell activation. Granulocyte-macrophage colony-stimulating factor treatment of cells caused increased association of PKCdelta and PI 3-kinase as did treatment of platelets with platelet-activating factor. Results using two PI 3-kinase inhibitors, wortmannin and LY-294002, showed that the former inhibited this association, while the latter did not, suggesting that PI 3-kinase lipid products may not be a prerequisite for the PI 3-kinase/PKCdelta association. Our results also suggest that tyrosine phosphorylation of PKCdelta is not involved in its association with PI 3-kinase.


INTRODUCTION

Cytokine stimulation of mitogenesis of hematopoietic cells is known to occur through at least two signaling pathways, both of which depend on tyrosine phosphorylation of key regulatory proteins; one is the p21ras/mitogen-activated protein kinase network and the other is the PI1 3-kinase pathway. Following ligand binding, the common beta  subunit of receptors for interleukin (IL)-3, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF) becomes tyrosine-phosphorylated (1, 2). Several other signaling proteins including JAK-2 (3), STAT-5 (4), p46, and p52 Shc (5, 6), p42/44 mitogen-activated protein kinases (7, 8), and SH-PTP2 (9) become tyrosine-phosphorylated as well. This cascade of tyrosine phosphorylation is thought to be initiated by the activation of the receptor-associated JAK-2 kinase and the subsequent phosphorylation of the receptor (3), although many of the details of the subsequent events have yet to be worked out. Tyrosine phosphorylation of Shc, followed by SH2-mediated association with the adaptor protein Grb-2 and the p21ras activator, m-SOS1, have been shown to be involved in the activation of p21ras (5, 6, 10), and activation of PI 3-kinase in hemopoietic cells is a result of cytokine-induced association of PI 3-kinase with specific tyrosine-phosphorylated proteins (11, 12, 13, 14). A tyrosine-phosphorylated 70-kDa substrate was shown to associate with PI 3-kinase following treatment of cells with IL-3 or GM-CSF (14), although this substrate was subsequently shown to be the tyrosine phosphatase, SH-PTP2, and its association may be indirect in a complex with Grb-2 (9).

The involvement of p21ras in mitogenesis is well understood, but the role of PI 3-kinase, which is thought to be essential as well (15), is less well characterized. Recent evidence suggests that two serine/threonine kinases, p70 S6 kinase (16, 17) and PKB (18), are thought to be activated downstream of PI 3-kinase. In hemopoietic cells, we showed previously that IL-3, IL-5, and GM-CSF as well as IL-4 and Steel factor all activate PI 3 kinase (14), and indeed, this signal is important in the ability of cytokines to inhibit apoptosis (19).

An intriguing set of observations made in the past few years has suggested that PI 3,4-P2 and PI 3,4,5-P3 can activate several novel and atypical PKC isoforms (PKCepsilon , -delta , -zeta , and -eta ) (20, 21). These results were obtained from in vitro assays, but the mechanism whereby PKC isoforms may be activated by PI 3-kinase in vivo is not known. The activation of PKC activity by cytokines has been reported in a few publications (22, 23), but it is not clear how this may occur. In the case of cytokines such as IL-3, IL-5, and GM-CSF, there is no evidence that a classical PI-phospholipase C pathway is operating, although evidence for increased production of diacylglycerol derived from phosphatidylcholine has been reported (24, 25, 26).

In an effort to further delineate pathways operating downstream of the related receptors for IL-3, IL-5, and GM-CSF, we have examined the role of PKC isoforms. This is a complex task, as there are at least 11 distinct family members that may be regulated by several independent mechanisms. In this report, we focus on the potential interaction of one specific PKC isoform, PKCdelta , with the PI 3-kinase enzyme. We find that the two enzymes can be co-immunoprecipitated as shown both by immunoblotting and enzyme activities. Furthermore, the association is modulated by cytokines, particularly by GM-CSF, in a human hemopoietic cell line. In another system, platelets activated by platelet-activating factor (PAF), we can also demonstrate an increase in the association between the two enzymes following activation of the cells. In addition, increased tyrosine phosphorylation of PKCdelta in response to Fcepsilon RI receptor activation in another cell type does not lead to any change in association between PKCdelta and PI 3-kinase. Therefore, we have discovered an association between PI 3-kinase and one specific PKC isoform that is probably independent of tyrosine phosphorylation of PKCdelta and is somehow modulated by specific receptor-mediated events.


EXPERIMENTAL PROCEDURES

Cells

TF-1 cells, a human erythroleukemia cell line (a kind gift from Dr. T. Kitamura, DNAX, Palo Alto, CA), were maintained in RPMI 1640 (Life Technologies, Inc.) with 10% fetal bovine serum (Intergen) plus 5 ng/ml IL-5 (purified recombinant human IL-5 prepared in a baculovirus expression system was kindly provided by Dr. D. Nicholson, Merck-Frosst, Kirkland, Quebec). In experiments in which cells were stimulated with cytokines, human recombinant cytokines were used; IL-3 and GM-CSF were from R&D Systems and IL-5 as described above. RBL-2H3 cells (a kind gift from Dr. John Rivera, NIH) were maintained in RPMI 1640 with 10% fetal bovine serum. Cells were trypsinized and passaged every 3 days.

Cytokine Stimulation and Immunoprecipitations

TF-1 cells, grown in complete RPMI with IL-5, were placed in cytokine-free medium with 1% serum 18 h prior to assay. Cells (5 × 106/500 µl) were washed three times in Hanks' balanced salt solution buffered with 20 mM Hepes, pH 7.4, and then preincubated in RPMI 1640 buffered with 20 mM Hepes, pH 7.4, at 37 °C for 30 min. Recombinant human GM-CSF (50 ng/ml), IL-3 (100 ng/ml), or IL-5 (500 ng/ml) were added for 15 min. Cells were solubilized in 500 µl of solubilization buffer (50 mM Tris-Cl, pH 7.7, 1% Triton X-100, 10% glycerol, 100 mM NaCl, 2.5 mM EDTA, 10 mM NaF, 0.2 mM Na3VO4, 1 mM Na2MoO4, 40 µg/ml phenylmethylsulfonyl fluoride, 1 µM pepstatin, 0.5 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor), centrifuged to remove debris, and then mixed with immunoprecipitating antibodies (anti-PKCdelta mouse monoclonal (Transduction Laboratories; 2 µg/500 µl of solubilization buffer), anti-PKCepsilon rabbit polyclonal IgG (Life Technologies, Inc.; 4 µg/500 µl of cell lysate), or anti-p85 rabbit polyclonal antiserum (raised against the p85 SH2-glutathione S-transferase fusion protein; a kind gift from Dr. Melanie Welham; 1 µl/500 µl of cell lysate) for 1 h on ice. Following addition of protein A-Sepharose beads (Pharmacia Biotech Inc.), samples were rotated at 4 °C for 1 h. The beads were washed 5 times with cold solubilization buffer. For immunoblots, proteins were eluted with SDS sample buffer containing 2-mercaptoethanol and boiled at 90 °C for 1 min prior to loading on 8.0% polyacrylamide gels using an acrylamide:bis ratio of 118:1. Proteins were transferred onto nitrocellulose using an LKB Novablot semi-dry transfer apparatus. The nitrocellulose blots were preincubated with Tris-buffered saline (5% bovine serum albumin, 1% ovalbumin, 0.05% NaN3) when blotted with anti-phosphotyrosine antibody 4G10 (Upstate Biotechology Inc., Lake Placid, NY), anti-p85, or anti-p110 (Santa Cruz Biotechology), or they were blocked using 5% skim milk powder for immunoblots with anti-PKCdelta , -epsilon , -alpha , -beta , -µ, or -zeta (Santa Cruz Biotechology).

PI 3-Kinase Activity

Following immunoprecipitation as described above, beads were used to assay for PI 3-kinase activity as described (14, 27). Briefly, the beads were washed twice with solubilization buffer and three times with 10 mM Tris-Cl buffer, pH 7.4. Phosphatidylinositol (10 µg/sample) in 30 mM Hepes, pH 7.4, and 40 µl of kinase buffer (30 mM Hepes, pH 7.4, 30 mM MgCl2, 50 µM ATP, 200 µM adenosine, [32P]ATP 10 µCi/µl) were added to the beads. The reaction was stopped after 15 min with 1 N HCl. Chloroform:methanol (1:1) was used to extract the lipid, and the labeled PI-3-P was separated by thin layer chromatography using oxalate-treated aluminum-backed silica gels (EM Scientific) and solvent comprised of NH4OH:water:methanol:chloroform. Rabbit platelets were prepared as described (28).

Fcepsilon RI Cross-linking in RBL-2H3 Cells

RBL-2H3 cells were trypsinized and washed in RPMI with serum. Cells were passively sensitized by incubation in the same medium with supernatant from a monoclonal antibody line producing IgE specific for dinitrophenol (a kind gift from Dr. John Rivera, NIH) at a dilution of 1:25. After 1 h at 37 °C, cells were washed twice in Tyrode's buffer, pH 7.4, with Ca2+ and Mg2+ added, and resuspended in the same buffer at 5 × 106 cells/ml. Cross-linking of the Fcepsilon RI receptor was achieved by addition of dinitrophenol-human serum albumin (Sigma) at a final concentration of 400 ng/ml. At various times, cells were centrifuged, then solubilized, and PKCdelta -immunoprecipitated as described above.


RESULTS AND DISCUSSION

The association of PKC isoforms delta  and epsilon  with PI 3-kinase was examined in the erythroleukemia cell line TF-1. Cell lysates from TF-1 cells, immunoprecipitated with antibodies to either PKCdelta or PKCepsilon and analyzed by immunoblotting with antibodies to the p85 or the p110 subunits of PI 3-kinase, showed that PI 3-kinase was being co-immunoprecipitated (Fig. 1, A and B, and Fig. 2). In reciprocal experiments, immunoprecipitation with antibody to p85 co-immunoprecipitated PKCdelta and -epsilon , as detected by immunoblotting. Other PKC isoforms found in TF-1 cells include alpha , beta , µ, zeta , and theta .2 None of the latter PKC isoforms were found to co-immunoprecipitate with PI 3-kinase, as determined by immunoblotting following immunoprecipitation with anti-p85 antibody, either in untreated cells or following stimulation with GM-CSF, IL-3, or IL-5 (data not shown).


Fig. 1. Anti-PKCdelta immunoprecipitates from TF-1 cell lysates contain PI 3-kinase. A, control samples indicate a basal level of PI 3-kinase association with PKCdelta . This association is dramatically enhanced by stimulation with GM-CSF, slightly with IL-5, and not at all with IL-3. B, the same blot washed (without stripping) and reprobed with antibody to PI 3-kinase subunit p110, revealing a similar pattern of PI 3-kinase association with PKCdelta . C, the same blot washed and reprobed with anti-PKCdelta to verify equal amounts of immunoprecipitated PKCdelta in all samples. These blots are representative of three independent experiments. Ippt, immunoprecipitate.


Fig. 2. TF-1 cell lysates immunoprecipitated with anti-PKCepsilon antibody and analyzed by immunoblotting contain PI 3-kinase. Control samples indicate a basal level of PI 3-kinase association with PKCepsilon . This association is not enhanced by cytokine stimulation and is not affected to a significant extent by 100 nM WM pretreatment of cells. This blot is representative of three independent experiments. Ippt, immunoprecipitate.

We next determined if this association was inducible by cytokine stimulation. After 15 min of stimulation with GM-CSF, there was an increased association of PI 3-kinase in anti-PKCdelta immunoprecipitates. This increased association was marginal in IL-5-treated cells but was not evident in IL-3-treated cells (Fig. 1, A and B). There was no detectable increase in PI 3-kinase protein in any of the PKCepsilon immunoprecipitates (Fig. 2). The difference in the effect using GM-CSF compared with IL-3 was very reproducible at this time point, but further studies should be done to test additional times.

To investigate whether the PI 3-kinase co-immunoprecipitated with PKCdelta or PKCepsilon remains active, anti-PKCdelta and anti-PKCepsilon immunoprecipitates were analyzed for PI 3-kinase activity in vitro. GM-CSF stimulation of the cells led to increased PI 3-kinase activity associated with PKCdelta compared with control samples or IL-5- or IL-3-stimulated cells (Fig. 3A), thereby correlating with the detection of PI 3-kinase in immunoblots. Anti-PKCepsilon immunoprecipitates also contained active PI 3-kinase; however, the PI 3-kinase activity was not affected by cytokine treatment of cells.


Fig. 3. Cell lysates immunoprecipitated with anti-PKCdelta contain active PI 3-kinase. A, immunoblot analysis demonstrates a reduction in PI 3-kinase association with PKCdelta when cells are pretreated with WM specifically in the IL-5-stimulated and GM-CSF-stimulated samples. B, the same immunoblot washed and reprobed with anti-PKCdelta to confirm an equal amount of PKCdelta in each sample. C, a basal level of PI 3-kinase activity is present in the immunoprecipitates in cells that were starved of cytokine overnight. GM-CSF-stimulated cells show an average of 2.25-fold increased activity from three experiments, based on counts/min incorporated into phosphatidylinositol. WM pretreatment of cells results in decreased PI 3-kinase activity in the immunoprecipitates from control (50% decrease), IL-5-treated cells (70% decrease), and GM-CSF-treated cells (70% decrease). Ippt, immunoprecipitate.

We next studied the role of PI 3-kinase activity in mediating the association with PKCdelta , taking advantage of two potent inhibitors of PI 3-kinase, wortmannin (WM) and LY-294002. Cells were pretreated with 100 nM WM or 50 µM LY-294002 prior to cytokine stimulation, conditions that are known to inhibit the majority of PI 3-kinase activity (29, 30).3 WM decreased the association of PKCdelta with PI 3-kinase in all cases (Fig. 3, A and B), but LY-294002 had no effect (data not shown). The relative decreases were consistently more pronounced in GM-CSF- and IL-5-treated cells than in IL-3-treated cells. WM is known to bind covalently to the active site of the p110 subunit, while LY-294002 is a competitive inhibitor. The contrasting results between WM and LY-294002 suggest that the PI 3-kinase/PKCdelta association is not modulated by the lipid products of PI 3-kinase activity but may be affected by alterations of the p110 subunit caused by WM. Alternatively, we cannot rule out the possibility that WM is having its effect on the PI 3-kinase/PKCdelta association independently of its effect on PI 3-kinase activity. Other inhibitory effects of WM have been described (31), and in our laboratory we have recently shown that WM has inhibitory effects on other kinases that are not seen with concentrations of LY-294002 that cause an equivalent inhibition of PI 3-kinase activity.3

Recent reports have described tyrosine phosphorylation of PKCdelta following stimulation with 12-O-tetradecanoylphorbol-13-acetate, carbachol, substance P, or Fcepsilon RI cross-linking (32, 33, 34). In TF-1 cells, a faint band is detected in anti-phosphotyrosine blots of anti-PKCdelta immunoprecipitates, and this band comigrates with PKCdelta (data not shown). However, we have been unable to detect any differences in the levels of tyrosine phosphorylation following cytokine stimulation. Phosphoamino acid analysis of PKCdelta will be necessary to confirm whether PKCdelta is being tyrosine-phosphorylated to any significant extent. In another independent system, we have confirmed the results of Haleem-Smith et al. (34), showing that cross-linking of the Fcepsilon RI receptor in RBL-2H3 cells leads to a large increase in tyrosine phosphorylation of PKCdelta (Fig. 4A), but interestingly, no PI 3-kinase was present in PKCdelta immunoprecipitates, either before or after receptor activation (Fig. 4B). Together, these results strongly suggest that the association between PI 3-kinase and PKCdelta that we have observed is independent of PKCdelta tyrosine phosphorylation and is therefore not likely to be mediated by the SH2 domains of the PI 3-kinase p85 subunit.


Fig. 4. Tyrosine phosphorylation of PKCdelta does not result in its association with PI 3-kinase. RBL-2H3 cells were passively sensitized with specific IgE and then either left untreated or stimulated by addition of antigen for 1 min or 10 min. A, anti-phosphotyrosine immunoblots of PKCdelta immunoprecipitates show that cross-linking of the Fcepsilon RI receptor results in increased tyrosine phosphorylation in RBL-2H3 cells and increased tyrosine phosphorylation of PKCdelta . B, in the same immunoprecipitates, there was no evidence for PI 3-kinase being associated, although the p85 subunit of PI 3-kinase could be easily detected in the whole cell extracts. The whole cell extracts represent protein from 1 × 105 cells, and the immunoprecipitatesw ere from 5 × 106 cells. Ippt, immunoprecipitate; Pre-IP, cell extract prior to immunoprecipitation.

To determine if PI 3-kinase associates with PKC isoforms in any other signaling systems we next investigated rabbit platelets treated with the potent agonist, PAF. PAF-treated platelets also showed an increase in PI 3-kinase protein co-immunoprecipitated with PKCdelta , compared with controls, as determined on immunoblots using anti-p85 antibodies (Fig. 5A). This association was again inhibited by WM. The PI 3-kinase was active in the PKCdelta immunoprecipitates as determined by an in vitro PI 3-kinase assay (Fig. 5B).


Fig. 5. Platelet lysates immunoprecipitated with anti-PKCdelta antibody also contain PI 3-kinase. A, immunoblot analysis of anti-PKCdelta immunoprecipitates of platelet lysates revealed the presence of PI 3-kinase. Treatment of platelets with platelet-activating factor increased the amount of PKCdelta associated with PI 3-kinase. Pretreatment of platelets for 10 min with 100 nM WM decreases this association. The identity of the band below the PI 3-kinase p85 band is not known but may represent a degradation product. B, PI 3-kinase activity is present in the immunoprecipitates, and this activity is reduced by pretreatment of platelets with WM. Ippt, immunoprecipitate.

We also characterized the serine/threonine kinase activity in anti-p85 immunoprecipitates and to date have found Ca2+-independent protein serine/threonine kinase activity as evidenced by phosphorylation of a Ser-containing peptide substrate corresponding to the PKCepsilon pseudo-substrate site. There were no increases in kinase activity in response to calcium, and the activity was at least partially lipid-dependent. These features are consistent with the characteristics of PKCdelta and PKCepsilon activities. We are investigating this further to determine the role PI 3-kinase may play in regulation of the PKC activity, particularly that of PKCdelta .

The importance of PI 3-kinase in signal transduction has been pointed out in numerous publications over the past few years. There have been many proteins shown to associate with PI 3-kinase following stimulation of cells, generally as a result of tyrosine-phosphorylated proteins associating via the PI 3-kinase p85 SH2 domains. This type of association is known to result in PI 3-kinase activation, independent of the tyrosine phosphorylation of the p85 subunit itself (35). We demonstrate here for the first time that at least two members of the PKC family of enzymes, PKCdelta and PKCepsilon , also associate with PI 3-kinase, and in the case of PKCdelta , the association is increased upon stimulation of hemopoietic cells with GM-CSF or upon activation of platelets. In our system, PKCdelta appears to be constitutively tyrosine-phosphorylated to a small extent, as seen on immunoblots. However, we cannot discern differences in levels of tyrosine phosphorylation with cytokine stimulation. Several PKC isoforms contain the consensus sequence recognized by PI 3-kinase SH2 domains in the p85 subunit including PKCdelta , which has YNYM (36), and PKCepsilon , which has YEMM (37). However, the lack of increased tyrosine phosphorylation of PKCdelta following cytokine stimulation, along with the lack of PKCdelta /PI 3-kinase association in a system in which PKCdelta is heavily tyrosine-phosphorylated suggests that we are observing an association that is unlike previously demonstrated interactions with PI 3-kinase. However, we do not know whether we are observing a direct interaction or one that also involves other proteins.

In the TF-1 cells, IL-3, IL-5, and GM-CSF are each able to provide a complete mitogenic stimulus, while only GM-CSF and, to a lesser extent, IL-5 are able to cause increased PI 3-kinase/PKCdelta association. Coupled with the finding that PAF activation of platelets is able to increase the association, the results suggest that the functional role of this interaction may be unrelated to the mitogenic effect of cytokines. There have been conflicting reports regarding the role of PKCdelta in mitogenesis (38, 39). Furthermore, as suggested by Myers et al. (40), the association of PI 3-kinase with various proteins may be unrelated to a role for that enzyme in mitogenesis. One might also speculate that the PI 3-kinase/PKCdelta association could be related to the effects of GM-CSF and perhaps IL-5 on inducing differentiation, effects that are distinct from those of IL-3. Further studies will be required to delineate the exact function of this novel association as well as other systems in which this type of regulation may be occurring.


FOOTNOTES

*   This work was supported by a grant from the Medical Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Recipient of a Heart and Stroke Foundation of Canada traineeship.
§   Recipient of a Medical Research Council of Canada/British Columbia Lung Association Fellowship. To whom correspondence should be addressed: Dept. of Medicine, Jack Bell Research Centre, University of British Columbia, 2660 Oak St., Vancouver, B.C. V6H 3Z6, Canada. Tel.: 604-875-4707; Fax: 604-875-4497; E-mail, vince{at}brc.ubc.ca.
1   The abbreviations used are: PI, phosphatidylinositol; IL, interleukin; GM-CSF, granulocyte-macrophage colony-stimulating factor; PAF, platelet-activating factor; PKC, protein kinase C; WM, wortmannin.
2   S. L. Ettinger and V. Duronio, unpublished observations.
3   M. P. Scheid and V. Duronio, submitted for publication.

Acknowledgments

We thank David Fong for technical assistance and Dr. Michael Gold for helpful discussions.


REFERENCES

  1. Sakamaki, K., Miyajima, I., Kitamura, T., Miyajima, A. (1992) EMBO J. 11, 3541-3549 [Medline] [Order article via Infotrieve]
  2. Duronio, V., Clark-Lewis, I., Federsppiel, B., Wieler, J. S., Schrader, J. W. (1992) J. Biol. Chem. 267, 21856-21863 [Abstract/Free Full Text]
  3. Ihle, J., Witthuhn, B., Quelle, F., Yamamoto, K., Thierfelder, W., Krieder, B., Silvennoinen, O. (1994) Trends Biochem. Sci. 19, 222-227 [CrossRef][Medline] [Order article via Infotrieve]
  4. Mui, A. L., Wakao, H., O'Farrell, A., Harada, N., Miyajima, A. (1995) EMBO J. 14, 1166-1175 [Medline] [Order article via Infotrieve]
  5. Cutler, R. L., Liu, L., Damen, J. E., Krystal, G. (1993) J. Biol. Chem. 268, 21463-21465 [Abstract/Free Full Text]
  6. Welham, M. J., Duronio, V., Leslie, K. B., Bowtell, D., Schrader, J. W. (1994) J. Biol. Chem. 269, 21165-21176 [Abstract/Free Full Text]
  7. Okuda, K., Sanghera, J. S., Pelech, S. L., Kanakura, Y., Hallek, M., Griffin, J. D., Drucker, B. J. (1992) Blood 79, 2880-2887 [Abstract/Free Full Text]
  8. Welham, M. J., Duronio, V., Sanghera, J. S., Pelech, S. L., Schrader, J. W. (1992) J. Immunol. 149, 1683-1693 [Abstract]
  9. Welham, M. J., Dechert, U., Leslie, K. B., Jirik, F., Schrader, J. W. (1994) J. Biol. Chem. 269, 23764-23768 [Abstract/Free Full Text]
  10. McCormick, F. (1993) Nature 363, 15-16 [CrossRef][Medline] [Order article via Infotrieve]
  11. Wang, L.-M., Keegan, A. D., Paul, W. E., Heidaran, A., Gutkind, J. S., Pierce, J. H. (1992) EMBO J. 11, 4899-4908 [Medline] [Order article via Infotrieve]
  12. Damen, J. E., Mui, A. L., Puil, L., Pawson, T., Krystal, G. (1993) Blood 81, 3204-3210 [Abstract/Free Full Text]
  13. Corey, S., Eguinoa, A., Pyana-Theall, K., Bolen, J. B., Cantle, L., Mollinedo, F., Jackson, T. R., Hawkins, P. T., Stephens, L. R. (1993) EMBO J. 12, 2681-2690 [Medline] [Order article via Infotrieve]
  14. Gold, M., Duronio, V., Saxena, S. P., Schrader, J. W., Aebersold, R. (1994) J. Biol. Chem. 269, 5403-5412 [Abstract/Free Full Text]
  15. Fantl, W., Escobedo, J., Martin, G., Turnk, C., Rosario, M., McCormick, F., Williams, L. (1992) Cell 69, 413-423 [CrossRef][Medline] [Order article via Infotrieve]
  16. Han, J. W., Pearson, R. B., Dennis, P. B., Thomas, G. (1995) J. Biol. Chem. 270, 21396-21403 [Abstract/Free Full Text]
  17. Petritsch, C., Woscholski, R., Edelmann, H. M. L., Parker, P. J., Ballou, L. M. (1995) Eur. J. Biochem. 230, 431-438 [Medline] [Order article via Infotrieve]
  18. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., Tsichlis, P. N. (1995) Cell 81, 727-736 [CrossRef][Medline] [Order article via Infotrieve]
  19. Scheid, M. P., Lauener, R. W., Duronio, V. (1995) Biochem. J. 312, 159-162
  20. Toker, A., Meyer, M., Reddy, K. K., Falck, J. R., Aneja, R., Aneja, S., Parra, A., Burns, D. J., Ballas, L. M., Cantley, L. C. (1994) J. Biol. Chem. 269, 32358-32367 [Abstract/Free Full Text]
  21. Nakanishi, H., Brewer, K. A., Exton, J. H. (1993) J. Biol. Chem. 268, 13-16 [Abstract/Free Full Text]
  22. Farrar, W. L., Thomas, T. P., Anderson, W. B. (1985) Nature 315, 235-237 [CrossRef][Medline] [Order article via Infotrieve]
  23. Pelech, S. L., Paddon, H. B., Charest, D. L., Federsppiel, B. S. (1990) J. Immunol. 144, 1759-1766 [Abstract]
  24. Duronio, V., Nip, L., Pelech, S. L. (1989) Biochem. Biophys. Res. Commun. 164, 804-808 [CrossRef][Medline] [Order article via Infotrieve]
  25. Robinson, M., Chen, T., Warne, T. R. (1991) J. Immunol. 147, 2624-2629 [Abstract/Free Full Text]
  26. Bourgoin, S., Plante, E., Gaudry, M., Naccache, P., Bôrgeat, P., Poubelle, P. E. (1990) J. Exp. Med. 172, 767-777 [Abstract/Free Full Text]
  27. Gold, M. R., Chan, V. W.-F., Turck, C. W., DeFranco, A. L. (1992) J. Immunol. 148, 2012-2022 [Abstract]
  28. Pinkard, R. N., Farr, R. S., Hanahan, D. G. (1984) J. Immunol. 123, 1847-1853 [Abstract/Free Full Text]
  29. Arcaro, A., Wymann, M. P. (1993) Biochem. J. 296, 297-301
  30. Vlahos, C. J., Matter, W. F., Hui, K. Y., Brown, R. F. (1994) J. Biol. Chem. 269, 5241-5248 [Abstract/Free Full Text]
  31. Cross, M. J., Stewart, A., Hodgkin, M. N., Kerr, D. J., Wakelam, M. J. (1995) J. Biol. Chem. 270, 25352-25355 [Abstract/Free Full Text]
  32. Li, W., Mischak, H., Yu, J. C., Wang, L. M., Mushinski, J. F., Heidaran, M. A., Pierce, J. H. (1994) J. Biol. Chem. 269, 2349-2352 [Abstract/Free Full Text]
  33. Soltoff, S. P., Toker, A. (1995) J. Biol. Chem. 270, 13490-13495 [Abstract/Free Full Text]
  34. Haleem-Smith, H., Chang, E., Szallasi, Z., Blumberg, P. M., Rivera, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9112-9116 [Abstract/Free Full Text]
  35. Backer, J. M., Myers, M. G., Shoelson, S. E., Chin, D. J., Sun, X. J., Miralpeix, M., Hu, P., Margolis, B., Skolnik, E. Y., Schlessinger, J., White, M. (1992) EMBO J. 11, 3469-3479 [Medline] [Order article via Infotrieve]
  36. Mischak, H., Bodenteich, A., Kolch, W., Goodnight, J., Hofer, F., Mushinski, J. F. (1991) Biochemistry 30, 7925-7931 [CrossRef][Medline] [Order article via Infotrieve]
  37. Basta, P., Strickland, M. B., Holmes, W., Loomis, C. R., Ballas, L. M., Burns, D. J. (1992) Biochim. Biophys. Acta 1132, 154-160 [Medline] [Order article via Infotrieve]
  38. Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., Mushinski, J. F. (1993) J. Biol. Chem. 268, 6090-6096 [Abstract/Free Full Text]
  39. Ohno, S., Mizuno, K., Adachi, Y., Hata, A., Akitai, Y., Akimoto, K., Osada, S., Hirai, S., Suzuki, K. (1994) J. Biol. Chem. 269, 17495-17501 [Abstract/Free Full Text]
  40. Myers, M. G., Jr., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., White, M. F. (1994) J. Biol. Chem. 269, 28783-28789 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Li, Y. Wei, E. Babilonia, Z. Wang, and W.-H. Wang
Inhibition of phosphatidylinositol 3-kinase stimulates activity of the small-conductance K channel in the CCD
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F806 - F812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Santiago-Walker, A. J. Fikaris, G. D. Kao, E. J. Brown, M. G. Kazanietz, and J. L. Meinkoth
Protein Kinase C {delta} Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest
J. Biol. Chem., September 16, 2005; 280(37): 32107 - 32114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Sano, A. R. Leff, S. Myou, E. Boetticher, A. Y. Meliton, J. Learoyd, A. T. Lambertino, N. M. Munoz, and X. Zhu
Regulation of Interleukin-5-Induced {beta}2-Integrin Adhesion of Human Eosinophils by Phosphoinositide 3-Kinase
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 65 - 70.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. E. Kilpatrick, S. Sun, and H. M. Korchak
Selective regulation by {delta}-PKC and PI 3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C633 - C642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Runyan, H. W. Schnaper, and A.-C. Poncelet
The Phosphatidylinositol 3-Kinase/Akt Pathway Enhances Smad3-stimulated Mesangial Cell Collagen I Expression in Response to Transforming Growth Factor-{beta}1
J. Biol. Chem., January 23, 2004; 279(4): 2632 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Uthaisangsook, N. K. Day, R. Hitchcock, A. Lerner, M. James-Yarish, R. A. Good, and S. Haraguchi
Negative Regulation of Interleukin-12 Production by a Rapamycin-Sensitive Signaling Pathway: A Brief Communication
Experimental Biology and Medicine, October 1, 2003; 228(9): 1023 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. E. Runyan, H. W. Schnaper, and A.-C. Poncelet
Smad3 and PKC{delta} mediate TGF-{beta}1-induced collagen I expression in human mesangial cells
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F413 - F422.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. E. Bruckener, A. el Baya, H.-J. Galla, and M. A. Schmidt
Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP
J. Cell Sci., May 1, 2003; 116(9): 1837 - 1846.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K.-p. Liu, A. F. Russo, S.-c. Hsiung, M. Adlersberg, T. F. Franke, M. D. Gershon, and H. Tamir
Calcium Receptor-Induced Serotonin Secretion by Parafollicular Cells: Role of Phosphatidylinositol 3-Kinase-Dependent Signal Transduction Pathways
J. Neurosci., March 15, 2003; 23(6): 2049 - 2057.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. J. Stafford, S. P. Watson, and C. J. Pears
PKD: a new protein kinase C-dependent pathway in platelets
Blood, February 15, 2003; 101(4): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Ringshausen, F. Schneller, C. Bogner, S. Hipp, J. Duyster, C. Peschel, and T. Decker
Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta
Blood, November 15, 2002; 100(10): 3741 - 3748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Saksena, R. K. Gill, I. A. Syed, S. Tyagi, W. A. Alrefai, K. Ramaswamy, and P. K. Dudeja
Inhibition of apical Cl-/OH- exchange activity in Caco-2 cells by phorbol esters is mediated by PKCepsilon
Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1492 - C1500.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. G. Kayali, D. A. Austin, and N. J. G. Webster
Rottlerin Inhibits Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes by Uncoupling Mitochondrial Oxidative Phosphorylation
Endocrinology, October 1, 2002; 143(10): 3884 - 3896.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-W. Yang, J. Wang, T. Zheng, B. T. Altura, and B. M. Altura
Importance of PKC and PI3Ks in ethanol-induced contraction of cerebral arterial smooth muscle
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2144 - H2152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-W. Yang, J. Wang, T. Zheng, B. T. Altura, and B. M. Altura
Low [Mg2+]o induces contraction and [Ca2+]i rises in cerebral arteries: roles of Ca2+, PKC, and PI3
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2898 - H2907.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K.-p. Liu, S.-c. Hsiung, M. Adlersberg, T. Sacktor, M. D. Gershon, and H. Tamir
Ca2+-Evoked Serotonin Secretion by Parafollicular Cells: Roles in Signal Transduction of Phosphatidylinositol 3'-kinase, and the gamma and zeta Isoforms of Protein Kinase C
J. Neurosci., February 15, 2000; 20(4): 1365 - 1373.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. M Ward, M.-F. Brennan, V. M Jackson, and K. M Sanders
Role of PI3-kinase in the development of interstitial cells and pacemaking in murine gastrointestinal smooth muscle
J. Physiol., May 1, 1999; 516(3): 835 - 846.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z.-W. Hu, X.-Y. Shi, R. Z. Lin, and B. B. Hoffman
Contrasting Signaling Pathways of {alpha}1A- and {alpha}1B-Adrenergic Receptor Subtype Activation of Phosphatidylinositol 3-Kinase and Ras in Transfected NIH3T3 Cells
Mol. Endocrinol., January 1, 1999; 13(1): 3 - 14.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Canicio, E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman
p70 S6 Kinase Activation Is Not Required for Insulin-Like Growth Factor-Induced Differentiation of Rat, Mouse, or Human Skeletal Muscle Cells
Endocrinology, December 1, 1998; 139(12): 5042 - 5049.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Graness, A. Adomeit, R. Heinze, R. Wetzker, and C. Liebmann
A Novel Mitogenic Signaling Pathway of Bradykinin in the Human Colon Carcinoma Cell Line SW-480 Involves Sequential Activation of a Gq/11 Protein, Phosphatidylinositol 3-Kinase beta , and Protein Kinase Cepsilon
J. Biol. Chem., November 27, 1998; 273(48): 32016 - 32022.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Li, Y.-X. Jiang, J. Zhang, L. Soon, L. Flechner, V. Kapoor, J. H. Pierce, and L.-H. Wang
Protein Kinase C-delta Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation
Mol. Cell. Biol., October 1, 1998; 18(10): 5888 - 5898.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle and T. L. Bushman
IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways
Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G151 - G158.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. E. Davis, D. J. Straff, E. A. Weinstein, P. G. Bannerman, D. M. Correale, J. D. Rothstein, and M. B. Robinson
Multiple Signaling Pathways Regulate Cell Surface Expression and Activity of the Excitatory Amino Acid Carrier 1 Subtype of Glu Transporter in C6 Glioma
J. Neurosci., April 1, 1998; 18(7): 2475 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. M. Conus, B. A. Hemmings, and R. B. Pearson
Differential Regulation by Calcium Reveals Distinct Signaling Requirements for the Activation of Akt and p70S6k
J. Biol. Chem., February 20, 1998; 273(8): 4776 - 4782.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Hong, D. Dumenil, B. van der Loo, F. Goncalves, W. Vainchenker, and J. D. Erusalimsky
Protein Kinase C Mediates the Mitogenic Action of Thrombopoietin in c-Mpl-Expressing UT-7 Cells
Blood, February 1, 1998; 91(3): 813 - 822.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Kaliman, J. Canicio, P. R. Shepherd, C. A. Beeton, X. Testar, M. Palacín, and A. Zorzano
Insulin-like Growth Factors Require Phosphatidylinositol 3-Kinase to Signal Myogenesis: Dominant Negative p85 Expression Blocks Differentiation of L6E9 Muscle Cells
Mol. Endocrinol., January 1, 1998; 12(1): 66 - 77.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Inukai, M. Funaki, T. Ogihara, H. Katagiri, A. Kanda, M. Anai, Y. Fukushima, T. Hosaka, M. Suzuki, B.-C. Shin, et al.
p85alpha Gene Generates Three Isoforms of Regulatory Subunit for Phosphatidylinositol 3-Kinase (PI 3-Kinase), p50alpha , p55alpha , and p85alpha , with Different PI 3-Kinase Activity Elevating Responses to Insulin
J. Biol. Chem., March 21, 1997; 272(12): 7873 - 7882.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bahr, A. Rohwer, L. Stempka, G. Rincke, F. Marks, and M. Gschwendt
DIK, a Novel Protein Kinase That Interacts with Protein Kinase Cdelta . CLONING, CHARACTERIZATION, AND GENE ANALYSIS
J. Biol. Chem., November 10, 2000; 275(46): 36350 - 36357.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ettinger, S. L.
Right arrow Articles by Duronio, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ettinger, S. L.
Right arrow Articles by Duronio, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement